434.924.9333
Patient & Visitor Information

800.223.9173

Make an Appointment

434.924.9333

    

Cancer Center

Hematologic (Blood) Cancer

Under the leadership of UVA Cancer Center Director, Dr. Thomas Loughran, and Hematology/Oncology Division Chief, Dr. Michael Williams, UVA has accelerated its expertise in the treatment of cancers of the blood, marrow and lymphatic systems, including acute and chronic leukemia, LGL leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma and other rare hematologic malignancies.

Cancers We Treat

See All Cancers We Treat

Need a Second Opinion?

If you'd like to schedule an appointment for a second opinion, call 434.924.9333.

  

Need a Second Opinion?

If you'd like to schedule an appointment for a second opinion, call 434.924.9333.

Questions?

If you need to speak with someone about your appointment, call 434.924.9333.

  

Make an Appointment

If you'd like to make an appointment or get a second opinion, call 434.924.9333.

Google Search Cancer
Home > Cancers We Treat > Hematologic Cancer

Hematologic (Blood) Cancer Overview

Under the leadership of UVA Cancer Center Director, Dr. Thomas Loughran, UVA has accelerated it’s expertise in the treatment of cancers of the blood and lymphatic systems, including acute and chronic leukemia, LGL leukemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma and other hematologic malignancies.

Hematologic (Blood) Cancer

Under the leadership of UVA Cancer Center Director, Dr. Thomas Loughran, and Hematology/Oncology Division Chief, Dr. Michael Williams, UVA has accelerated its expertise in the treatment of cancers of the blood, marrow and lymphatic systems, including acute and chronic leukemia, LGL leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma and other rare hematologic malignancies.

LGL Leukemia Program & Registry

  • Led by UVA Cancer Center director and LGL leukemia founder, Thomas P. Loughran, Jr., the LGL Leukemia Program at UVA offers patients access to advanced treatment options, clinical trials and participation in the LGL Leukemia Registry, a research database exclusive to UVA. The registry and other efforts to better understand and treat the disease are ongoing and are a priority of the cancer center. Patients with LGL leukemia and their physicians are encouraged to contact the LGL clinic for appointment information or instructions to enroll in the registry. Travel assistance is available for patients who qualify.

Expertise in Hematologic Cancer Care

Advanced Treatments & Therapies

Dramatic advances have been made in recent years for most hematological cancers because of research. Novel targeted therapies, which complement or replace traditional chemotherapy and radiation treatments, are now routine for many hematological malignancies. We offer clinical trials for these disorders, with a focus on immunotherapy, targeted agents and new chemotherapy treatments.

UVA Hematologic Cancer Services

  • Multi-Disciplinary Team of Hematology Experts

    From hematopathologists, experts in identifying and diagnosing blood cancer, to hematologists, dedicated nurses and social workers, patients receive comprehensive care for their conditions. The cytogenetic and other hematology/oncology labs at UVA specialize in running tests that are critical in the diagnosis and treatment of rare and common blood cancers. Patients with these conditions often need long-term follow up and care which is a priority of the hematology team at the UVA Cancer Center.

    Targeted Therapies

    UVA offers the latest in targeted therapies including immunotherapy, which are antibody-based medicines, and novel agents such as tyrosine kinase inhibitors and immune-modulating agents. Patients at UVA have the benefit of access to clinical trials not offered at other cancer centers in the area as well as the latest in FDA-approved treatments as they are released.

Bone Marrow & Stem Cell Transplants

For Patients with Advanced Disease

UVA Stem Cell Transplant Program

For patients with high-risk and life-threatening blood diseases, UVA Cancer Center's Stem Cell Transplant Program provides additional treatment options that increase the likelihood of survival. 

Additional Resources

Stem Cell Transplant Program

Call us to schedule a consultation: 855.285.1122 or visit the program page for instructions on getting here and other important information.

Schedule an Appointment

Please call 855.285.1122 to schedule an appointment